MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, the company offers personal lines of property and casualty insurance, including private passenger automobile, homeowners', and personal excess liability insurance. Further, it provides fixed and variable annuities, and pension products; accident and health products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; credit insurance products; and protection against long-term health care services. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.
IPO Year: 2000
Exchange: NYSE
Website: metlife.com
Date | Price Target | Rating | Analyst |
---|---|---|---|
1/23/2025 | $97.00 | Market Perform | BMO Capital Markets |
10/9/2024 | $97.00 | Buy | TD Cowen |
9/5/2024 | $91.00 | Overweight | Barclays |
1/8/2024 | $80.00 | Neutral → Buy | Goldman |
11/17/2023 | $71.00 | Overweight | Barclays |
10/5/2023 | $71.00 | Hold | Deutsche Bank |
9/14/2023 | $58.00 → $72.00 | Hold → Buy | Jefferies |
1/9/2023 | $80.00 → $78.00 | Buy → Neutral | Goldman |
12/9/2022 | $86.00 → $82.00 | Buy → Hold | Jefferies |
9/22/2022 | Mkt Perform | Raymond James |